The role of interferon beta in neurological diseases and its potential therapeutic relevance
- 10 August 2024
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 981, 176882
Abstract
No abstract availableKeywords
Funding Information
- Shahid Beheshti University of Medical Sciences
This publication has 142 references indexed in Scilit:
- Identifying and verifying Huntington's disease subtypes: Clinical features, neuroimaging, and cytokine changesBrain and Behavior, 2024
- Type I interferon pathway in CNS homeostasis and neurological disordersGlia, 2017
- Type‐1 interferons contribute to the neuroinflammatory response and disease progression of the MPTP mouse model of Parkinson's diseaseGlia, 2016
- Pharmacokinetics, pharmacodynamics, and safety of peginterferon beta‐1a in subjects with normal or impaired renal functionThe Journal of Clinical Pharmacology, 2014
- Interferons in the central nervous system: A few instruments play many tunesGlia, 2013
- Oligodendroglia are limited in type I interferon induction and responsiveness in vivoGlia, 2012
- Toll‐like receptors 2 and 3 agonists differentially affect oligodendrocyte survival, differentiation, and myelin membrane formationJournal of Neuroscience Research, 2011
- Toll‐like receptors in central nervous system glial inflammation and homeostasisJournal of Neuroscience Research, 2006
- Interferon‐β stabilizes barrier characteristics of brain endothelial cells in vitroAnnals of Neurology, 2004
- Interferon modulates glucose-sensitive neurons in the hypothalamus.Experimental Brain Research, 1997